Results 121 to 130 of about 210,668 (403)
Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers
Background Impaired myocardial blood flow (MBF) in the absence of epicardial coronary disease is a feature of hypertrophic cardiomyopathy (HCM). Although most evident in hypertrophied or scarred segments, reduced MBF can occur in apparently normal segments.
Rebecca K. Hughes +14 more
wiley +1 more source
Paravalvular leakage (PVL) is not rare and can be a serious clinical problem in 1–5% of all valve replacement. There are inconclusive data regarding the incidence of PVR after aortic valve replacement (AVR) and mitral valve replacement (MVR).The aim of ...
Nedim Selimovic (Faisal Harthy) +2 more
doaj +1 more source
Early experience of TIARA transcatheter mitral valve replacement system.
Mitral regurgitation (MR) is a common valvular disorder that can result in congestive heart failure and cardiovascular death. Patient suffering from this condition are frequently not referred and thus the condition is under-treated.
A. Cheung
semanticscholar +1 more source
Septic emboli secondary to Infective Endocarditis [PDF]
A 31 year old lady was brought to casualty by a friend, unconscious and incontinent of urine and faeces. She was responsive to verbal stimuli with a Glasgow Come Scale (GCS) of 10 and noted to have a fever of 39.6oC.
Padovani, Luisa +2 more
core
Liver stiffness measurement for central venous pressure assessment. AUC, area under the curve; BMI, body mass index; CI, confidence interval; CVP, central venous pressure; HF, heart failure; LSM, liver stiffness measurement; LVEF, left ventricular ejection fraction. Abstract Aims Central venous pressure (CVP) is an important variable in assessing heart
Nicolas Girerd +16 more
wiley +1 more source
Transcatheter mitral valve repair and replacement
Mitral regurgitation is the valvular heart disease with the highest prevalence in the Western countries, and its prevalence increases with age.1 Conventional surgery provides excellent results in the younger population free of comorbidities, but up to 50% of the patients with severe mitral ...
Maisano, Francesco +3 more
openaire +5 more sources
D. Muller +17 more
semanticscholar +1 more source
Transcatheter aortic valve replacement in patients with concomitant mitral stenosis
AIMS Multivalvular disease is of increasing concern in elderly patients undergoing transcatheter aortic valve replacement (TAVR). The objective of the present analysis was to investigate the impact of concomitant mitral stenosis (MS) on clinical outcomes
M. Asami +9 more
semanticscholar +1 more source
In the PRIME‐MR study, patients with higher N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) tertiles more frequently reached death or heart failure hospitalization (HFH) within 3 years. Log‐transformed NT‐proBNP levels independently predicted the primary endpoint (adjusted hazard ratio 1.17, 95% confidence interval 1.07–1.28; p < 0.001).
Philipp von Stein +70 more
wiley +1 more source
The ADHF‐ED trial. ADHF, acutely decompensated heart failure; CHF, chronic heart failure; ED, emergency department; EF, ejection fraction; MRA, mineralocorticoid receptor antagonist; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide. Created with the support of AI (ChatGPT).
Michael Kunz +9 more
wiley +1 more source

